brinzolamide

FDA Drug Profile — BRINZOLAMIDE, Azopt

Drug Details

Generic Name
brinzolamide
Brand Names
BRINZOLAMIDE, Azopt
Application Number
ANDA204884
Sponsor
Bausch & Lomb Incorporated
NDC Codes
6
Dosage Forms
SUSPENSION/ DROPS, POWDER
Routes
OPHTHALMIC
Active Ingredients
BRINZOLAMIDE

Indications and Usage

1 INDICATIONS AND USAGE Brinzolamide ophthalmic suspension is a carbonic anhydrase inhibitor indicated in the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma. Brinzolamide ophthalmic suspension is a carbonic anhydrase inhibitor indicated for in the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma ( 1 )